Search

everythinglearnresearchcommunity

for

Search:↓

The type of PCOS a woman has doesn't strongly predict her skin or metabolic symptoms; obesity is a more important factor.

Hair loss affects quality of life, self-esteem, and confidence, but younger patients cope better.

Trichodynia is a painful scalp condition not directly linked to the amount or type of hair loss and may involve psychological factors, with treatments showing mixed results.

Skin tags in obese individuals may indicate higher cardiovascular risk.

Low serum ferritin is linked to hair loss in women.

Age, hair loss duration, menopause, and specific treatments affect hair density and caliber in female hair loss patients.

Hair loss caused by genetics and hormones; more research needed for treatments.

Genetic variation in the androgen receptor gene mainly causes early-onset hair loss, with maternal inheritance playing a key role.

Women with AGA often face anxiety, depression, and low self-esteem; psychological support is important.

More severe hair loss links to thicker heart fat, suggesting possible heart disease risk.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

G allele of AR Stul polymorphism linked to higher hair loss risk, especially in white people.

Using steroids can increase the risk of heart problems.

Early onset hair loss linked to genetics and androgen levels.

Mutations in the androgen receptor gene cause Androgen Insensitivity Syndrome, affecting sexual development.

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Finasteride use doesn't cause sexual dysfunction in men with hair loss.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

Minoxidil tretinoin liposomal based hydrogel shows promise for effective treatment of hair loss by delivering both drugs at the same time.

Young adults with hair loss face higher risk of stiff arteries.

Hair loss may indicate higher heart risk and metabolic issues.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.